These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31825972)

  • 1. IL-4/IL-13 polarization of macrophages enhances Ebola virus glycoprotein-dependent infection.
    Rogers KJ; Brunton B; Mallinger L; Bohan D; Sevcik KM; Chen J; Ruggio N; Maury W
    PLoS Negl Trop Dis; 2019 Dec; 13(12):e0007819. PubMed ID: 31825972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIM-1 serves as a receptor for Ebola virus in vivo, enhancing viremia and pathogenesis.
    Brunton B; Rogers K; Phillips EK; Brouillette RB; Bouls R; Butler NS; Maury W
    PLoS Negl Trop Dis; 2019 Jun; 13(6):e0006983. PubMed ID: 31242184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cathepsin B & L are not required for ebola virus replication.
    Marzi A; Reinheckel T; Feldmann H
    PLoS Negl Trop Dis; 2012; 6(12):e1923. PubMed ID: 23236527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ebolaviruses Associated with Differential Pathogenicity Induce Distinct Host Responses in Human Macrophages.
    Olejnik J; Forero A; Deflubé LR; Hume AJ; Manhart WA; Nishida A; Marzi A; Katze MG; Ebihara H; Rasmussen AL; Mühlberger E
    J Virol; 2017 Jun; 91(11):. PubMed ID: 28331091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola Virus Requires Phosphatidylserine Scrambling Activity for Efficient Budding and Optimal Infectivity.
    Acciani MD; Lay Mendoza MF; Havranek KE; Duncan AM; Iyer H; Linn OL; Brindley MA
    J Virol; 2021 Sep; 95(20):e0116521. PubMed ID: 34319156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the therapeutic effect of antibodies targeting the Ebola glycoprotein using a novel BSL2-compliant rVSVΔG-EBOV-GP infection model.
    Lee HN; McWilliams IL; Lewkowicz AP; Engel K; Ireland DDC; Kelley-Baker L; Thacker S; Piccardo P; Manangeeswaran M; Verthelyi D
    Emerg Microbes Infect; 2021 Dec; 10(1):2076-2089. PubMed ID: 34674613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of Human and Murine T-Cell Immunoglobulin Mucin Domain 4 (TIM-4) IgV Domain Residues Critical for Ebola Virus Entry.
    Rhein BA; Brouillette RB; Schaack GA; Chiorini JA; Maury W
    J Virol; 2016 Jul; 90(13):6097-6111. PubMed ID: 27122575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the inhibitory effect of an extract of Prunella vulgaris on Ebola virus glycoprotein (GP)-mediated virus entry and infection.
    Zhang X; Ao Z; Bello A; Ran X; Liu S; Wigle J; Kobinger G; Yao X
    Antiviral Res; 2016 Mar; 127():20-31. PubMed ID: 26778707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Niemann-pick C1 is essential for ebolavirus replication and pathogenesis in vivo.
    Herbert AS; Davidson C; Kuehne AI; Bakken R; Braigen SZ; Gunn KE; Whelan SP; Brummelkamp TR; Twenhafel NA; Chandran K; Walkley SU; Dye JM
    mBio; 2015 May; 6(3):e00565-15. PubMed ID: 26015498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mucin-Like Domain of Ebola Virus Glycoprotein Enhances Selective Oncolytic Actions against Brain Tumors.
    Zhang X; Zhang T; Davis JN; Marzi A; Marchese AM; Robek MD; van den Pol AN
    J Virol; 2020 Mar; 94(8):. PubMed ID: 32051271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ebola virus triggers receptor tyrosine kinase-dependent signaling to promote the delivery of viral particles to entry-conducive intracellular compartments.
    Stewart CM; Phan A; Bo Y; LeBlond ND; Smith TKT; Laroche G; Giguère PM; Fullerton MD; Pelchat M; Kobasa D; Côté M
    PLoS Pathog; 2021 Jan; 17(1):e1009275. PubMed ID: 33513206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism.
    González-Hernández M; Hoffmann M; Brinkmann C; Nehls J; Winkler M; Schindler M; Pöhlmann S
    J Virol; 2018 Jul; 92(13):. PubMed ID: 29669839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Naturally Occurring Polymorphism in the Base of Sudan Virus Glycoprotein Decreases Glycoprotein Stability in a Species-Dependent Manner.
    Lennemann NJ; Dillard J; Ruggio N; Cooney AL; Schaack GA; Davey RA; Maury W
    J Virol; 2021 Aug; 95(18):e0107321. PubMed ID: 34232742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ebola Virus Uptake into Polarized Cells from the Apical Surface.
    Hu M; Wang F; Li W; Zhang X; Zhang Z; Zhang XE; Cui Z
    Viruses; 2019 Dec; 11(12):. PubMed ID: 31810353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frontline Science: CD40 signaling restricts RNA virus replication in Mϕs, leading to rapid innate immune control of acute virus infection.
    Rogers KJ; Shtanko O; Stunz LL; Mallinger LN; Arkee T; Schmidt ME; Bohan D; Brunton B; White JM; Varga SM; Butler NS; Bishop GA; Maury W
    J Leukoc Biol; 2021 Feb; 109(2):309-325. PubMed ID: 32441445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination With a Highly Attenuated Recombinant Vesicular Stomatitis Virus Vector Protects Against Challenge With a Lethal Dose of Ebola Virus.
    Matassov D; Marzi A; Latham T; Xu R; Ota-Setlik A; Feldmann F; Geisbert JB; Mire CE; Hamm S; Nowak B; Egan MA; Geisbert TW; Eldridge JH; Feldmann H; Clarke DK
    J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S443-51. PubMed ID: 26109675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMP-activated protein kinase is required for the macropinocytic internalization of ebolavirus.
    Kondratowicz AS; Hunt CL; Davey RA; Cherry S; Maury WJ
    J Virol; 2013 Jan; 87(2):746-55. PubMed ID: 23115293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive functional analysis of N-linked glycans on Ebola virus GP1.
    Lennemann NJ; Rhein BA; Ndungo E; Chandran K; Qiu X; Maury W
    mBio; 2014 Jan; 5(1):e00862-13. PubMed ID: 24473128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
    Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.
    Marzi A; Wegele A; Pöhlmann S
    Virology; 2006 Sep; 352(2):345-56. PubMed ID: 16777170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.